AXSM
NASDAQ · Pharmaceuticals
Axsome Therapeutics Inc
$212.43
-0.42 (-0.20%)
Performance
1D
—
1W
—
1M
—
3M
—
6M
+15.94%
1Y
+103.63%
YTD
+18.88%
Open$212.73
Previous Close$212.85
Day High$216.56
Day Low$211.57
52W High$260.19
52W Low$96.09
Volume—
Avg Volume667.4K
Market Cap11.33B
P/E Ratio—
EPS$-3.74
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$171.07
Above
SMA 200
$131.37
Above
RSI (14)
51.8
Neutral
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
27 analysts
Price Target
-68.9% upside
Current
$212.43
$212.43
Target
$66.03
$66.03
$47.60
$66.03 avg
$88.20
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 667.10M | 1.74B | 1.62B |
| Net Income | -191,379,237 | 523.27M | 458.37M |
| Profit Margin | -28.7% | 30.1% | 28.3% |
| EBITDA | -178,421,728 | 948.73M | 868.54M |
| Free Cash Flow | — | 423.20M | 592.85M |
| Rev Growth | +133.7% | -6.3% | -6.3% |
| Debt/Equity | 3.25 | 0.60 | 0.65 |
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,189.35 | +1.67% | 42.6 | 1.08T |
| JNJ | Johnson & Johnson | $257.21 | -0.15% | 29.5 | 621.32B |
| MRK | Merck & Co. Inc. | $128.63 | +0.23% | 36.1 | 322.90B |
| PFE | Pfizer Inc. | $25.98 | +0.64% | 19.1 | 143.06B |
| BMY | Bristol-Myers Squibb Co | $64.09 | +0.72% | 22.3 | 132.99B |
| ZTS | Zoetis Inc | $76.68 | +3.07% | 12.1 | 32.02B |